Home › Compare › HUMDF vs ADC

HUMDF vs ADC: Dividend Comparison 2026

HUMDF yields 484.14% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HUMDF wins by $47899.83M in total portfolio value
10 years
HUMDF
HUMDF
● Live price
484.14%
Share price
$0.41
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47900.01M
Annual income
$34,060,653,223.60
Full HUMDF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — HUMDF vs ADC

📍 HUMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHUMDFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HUMDF + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HUMDF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUMDF
Annual income on $10K today (after 15% tax)
$41,152.26/yr
After 10yr DRIP, annual income (after tax)
$28,951,555,240.06/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, HUMDF beats the other by $28,951,486,562.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUMDF + ADC for your $10,000?

HUMDF: 50%ADC: 50%
100% ADC50/50100% HUMDF
Portfolio after 10yr
$23950.10M
Annual income
$17,030,367,010.45/yr
Blended yield
71.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

HUMDF
No analyst data
Altman Z
3.9
Piotroski
5/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUMDF buys
0
ADC buys
0
No recent congressional trades found for HUMDF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHUMDFADC
Forward yield484.14% ✓4.13%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$47900.01M ✓$178.9K
Annual income after 10y$34,060,653,223.60 ✓$80,797.29
Total dividends collected$46687.76M ✓$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: HUMDF vs ADC ($10,000, DRIP)

YearHUMDF PortfolioHUMDF Income/yrADC PortfolioADC Income/yrGap
1← crossover$59,114$48,414.43$10,990$580.36+$48.1K → HUMDF
2$330,728$267,475.81$12,301$860.26+$318.4K → HUMDF
3$1,752,431$1,398,551.73$14,104$1,298.62+$1.74M → HUMDF
4$8,800,812$6,925,711.29$16,691$2,008.16+$8.78M → HUMDF
5$41,922,789$32,505,919.38$20,580$3,205.09+$41.90M → HUMDF
6$189,569,894$144,712,509.91$26,754$5,330.02+$189.54M → HUMDF
7$814,403,207$611,563,420.90$37,196$9,345.14+$814.37M → HUMDF
8$3,326,842,984$2,455,431,552.18$56,244$17,523.09+$3326.79M → HUMDF
9$12,933,979,587$9,374,257,594.32$94,286$35,736.21+$12933.89M → HUMDF
10$47,900,011,382$34,060,653,223.60$178,949$80,797.29+$47899.83M → HUMDF

HUMDF vs ADC: Complete Analysis 2026

HUMDF — Stock

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia. The company was incorporated in 2011 and is based in Beijing, China.

Full HUMDF Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this HUMDF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUMDF vs SCHDHUMDF vs JEPIHUMDF vs OHUMDF vs KOHUMDF vs MAINHUMDF vs NNNHUMDF vs EPRTHUMDF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.